India - English - Central Drugs Standard Control Organization

novartis - oestradiol - 25/50;mcg/patch - 2/2

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - estradiol 3mg equivalent to 100 µg/24h;   - transdermal patch - 100 mcg/24h - active: estradiol 3mg equivalent to 100 µg/24h  

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - estradiol 0.75mg equivalent to 25 µg/24h;   - transdermal patch - 25 mcg/24h - active: estradiol 0.75mg equivalent to 25 µg/24h  

New Zealand - English - Medsafe (Medicines Safety Authority)

servier laboratories nz ltd - estradiol 1.5mg equivalent to 5 0µg/24h;   - transdermal patch - 50 mcg/24h - active: estradiol 1.5mg equivalent to 5 0µg/24h  

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - estradiol 8mg (releases 100 µg/24 hours);   - transdermal patch - 100 mcg/24h - active: estradiol 8mg (releases 100 µg/24 hours)   excipient: ethanol hyprolose

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - estradiol 2mg (releases 25 µg/24 hours);   - transdermal patch - 25 mcg/24h - active: estradiol 2mg (releases 25 µg/24 hours)   excipient: ethanol hyprolose

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - estradiol 4mg (releases 50 µg/24 hours);   - transdermal patch - 50 mcg/24h - active: estradiol 4mg (releases 50 µg/24 hours)   excipient: ethanol hyprolose

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - estramustine phosphate 140 mg - capsules - estramustine - second line therapy in prostatic carcinoma in advanced stages.

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma egypt - system - 25 mcg

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma egypt - system - 25 mcg